MLTXMoonLake Immunotherapeutics
$10.83-80% 1Y
$10.83
$6.2452 weeks$61.99
The financials
MoonLake Immunotherapeutics by the numbers
The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$62M | −$61M | n/a |
| Net income | −$62M | −$55M | n/a |
| Diluted EPS | −$0.84 | −$0.87 | n/a |